Resident's Forum
The Good and Bad News About New Drugs for Treating Alopecia Areata
FR-Luces y sombras de nuevos fármacos en el tratamiento de la alopecia areata
D. Morgado-Carrasco, E. Rodríguez-Lobato, J. Riera-Monroig, J. Ferrando
Autor para correspondencia
Department of Dermatology, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
Leído
7327
Vecesse ha leído el artículo
2836
Total PDF
4491
Total HTML
Compartir estadísticas
array:23 [ "pii" => "S1578219017303682" "issn" => "15782190" "doi" => "10.1016/j.adengl.2017.11.012" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "1696" "copyrightAnyo" => "2017" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2018;109:69-70" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 418 "formatos" => array:3 [ "EPUB" => 23 "HTML" => 288 "PDF" => 107 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731017302648" "issn" => "00017310" "doi" => "10.1016/j.ad.2017.05.003" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "1696" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2018;109:69-70" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 297 "formatos" => array:3 [ "EPUB" => 4 "HTML" => 207 "PDF" => 86 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Foro de Residentes</span>" "titulo" => "FR-Luces y sombras de nuevos fármacos en el tratamiento de la alopecia areata" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "69" "paginaFinal" => "70" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "The Good and Bad News About New Drugs for Treating Alopecia Areata" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "D. Morgado-Carrasco, E. Rodríguez-Lobato, J. Riera-Monroig, J. Ferrando" "autores" => array:4 [ 0 => array:2 [ "nombre" => "D." "apellidos" => "Morgado-Carrasco" ] 1 => array:2 [ "nombre" => "E." "apellidos" => "Rodríguez-Lobato" ] 2 => array:2 [ "nombre" => "J." "apellidos" => "Riera-Monroig" ] 3 => array:2 [ "nombre" => "J." "apellidos" => "Ferrando" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219017303682" "doi" => "10.1016/j.adengl.2017.11.012" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017303682?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017302648?idApp=UINPBA000044" "url" => "/00017310/0000010900000001/v1_201801020548/S0001731017302648/v1_201801020548/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219017303694" "issn" => "15782190" "doi" => "10.1016/j.adengl.2017.11.013" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "1735" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2018;109:71-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 308 "formatos" => array:3 [ "EPUB" => 21 "HTML" => 216 "PDF" => 71 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Videos of Surgical Procedures in Dermatology</span>" "titulo" => "Type <span class="elsevierStyleSmallCaps">I</span> Keystone Island Flap" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "71" "paginaFinal" => "72" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Colgajo de keystone tipo <span class="elsevierStyleSmallCaps">i</span>" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1565 "Ancho" => 1625 "Tamanyo" => 245408 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Design of the type<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleSmallCaps">i</span> keystone flap.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "H.A. Cocunubo-Blanco, A. Pérez-Bustillo, E. Manrrique, M.Á. Rodríguez-Prieto" "autores" => array:4 [ 0 => array:2 [ "nombre" => "H.A." "apellidos" => "Cocunubo-Blanco" ] 1 => array:2 [ "nombre" => "A." "apellidos" => "Pérez-Bustillo" ] 2 => array:2 [ "nombre" => "E." "apellidos" => "Manrrique" ] 3 => array:2 [ "nombre" => "M.Á." "apellidos" => "Rodríguez-Prieto" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731017303459" "doi" => "10.1016/j.ad.2017.05.015" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017303459?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017303694?idApp=UINPBA000044" "url" => "/15782190/0000010900000001/v1_201801020547/S1578219017303694/v1_201801020547/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1578219017303670" "issn" => "15782190" "doi" => "10.1016/j.adengl.2017.11.011" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "1749" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2018;109:67-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 390 "formatos" => array:3 [ "EPUB" => 22 "HTML" => 286 "PDF" => 82 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Practical Dermoscopy</span>" "titulo" => "Slow-Growing Pink Papule" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "67" "paginaFinal" => "68" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Pápula rosada de crecimiento lento" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 917 "Ancho" => 2104 "Tamanyo" => 158553 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A, Dermoscopic image showing structureless pale pink areas (asterisks) within the lesion and prominent peripheral vascularity. B, Detail of the blood vessels with the characteristic cherry blossom images.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J.L. Ramírez-Bellver, S. Saenz Guirado" "autores" => array:2 [ 0 => array:2 [ "nombre" => "J.L." "apellidos" => "Ramírez-Bellver" ] 1 => array:2 [ "nombre" => "S." "apellidos" => "Saenz Guirado" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731017303770" "doi" => "10.1016/j.ad.2017.06.011" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017303770?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017303670?idApp=UINPBA000044" "url" => "/15782190/0000010900000001/v1_201801020547/S1578219017303670/v1_201801020547/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Resident's Forum</span>" "titulo" => "The Good and Bad News About New Drugs for Treating Alopecia Areata" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "69" "paginaFinal" => "70" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "D. Morgado-Carrasco, E. Rodríguez-Lobato, J. Riera-Monroig, J. Ferrando" "autores" => array:4 [ 0 => array:2 [ "nombre" => "D." "apellidos" => "Morgado-Carrasco" ] 1 => array:2 [ "nombre" => "E." "apellidos" => "Rodríguez-Lobato" ] 2 => array:2 [ "nombre" => "J." "apellidos" => "Riera-Monroig" ] 3 => array:4 [ "nombre" => "J." "apellidos" => "Ferrando" "email" => array:1 [ 0 => "juanferrandobarbera@gmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Department of Dermatology, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "FR-Luces y sombras de nuevos fármacos en el tratamiento de la alopecia areata" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Alopecia areata (AA) is an autoimmune disease that is difficult to treat and has a limited therapeutic arsenal. In some publications it has been suggested that the lipid-lowering drugs, statins, may be effective in the treatment of a number of dermatoses, such as psoriasis. In 2015, Lattouf et al.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a> conducted a prospective study of 29 patients with AA affecting 40% to 70% of the scalp, treating them with a combination of simvastatin, 40<span class="elsevierStyleHsp" style=""></span>mg, plus ezetimibe, 10<span class="elsevierStyleHsp" style=""></span>mg, once a day for 24 weeks. By 16 to 24 weeks, 14 of the 29 patients had developed hair regrowth greater than 20%. Subsequently, treatment was withdrawn in 7 of the responding patients, leading to recurrence of the alopecia in 5 of them. These promising results were considered to be produced by the anti-inflammatory and immunomodulatory effects of the statins. However, a similar study performed recently, using simvastatin plus ezetimibe at the same dose and for the same period in 20 patients with severe AA (involvement of more than 70% of the scalp), produced little effect, with sparse hair growth in only 1 patient. Additionally, 15% of the individuals presented adverse effects, such as headache or myalgia.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> The difference in the results of these studies could be due to the different degrees of severity of AA in the patients studied. Mild or moderate AA can improve spontaneously, whereas severe forms tend to be more refractory to treatment. Our experience has been similar. We have observed a poor clinical response to simvastatin plus ezetimibe in severe AA.</p><p id="par0010" class="elsevierStylePara elsevierViewall">In recent years, there have been reports of cases of AA with a clinical response to treatment with Janus kinase (JAK) inhibitors in patients with myeloproliferative disorders or psoriatic arthritis, and JAK/STAT (signal transducer and activator of transcription) overexpression has been detected in AA.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> A recent clinical trial using ruxolitinib, a JAK1/2 inhibitor, 20<span class="elsevierStyleHsp" style=""></span>mg by mouth twice a day for 3 to 6 months, produced encouraging results in 12 patients with moderate or severe AA followed up for 3 months after completing treatment: 75% of the individuals presented considerable hair growth (mean, 92%). Surprisingly, this hair growth was observed after 4 weeks of treatment and the incidence of adverse effects was very low. Some patients presented hair loss after treatment withdrawal, but none returned to pretreatment levels.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a> Similar findings were reported in a retrospective study of 90 patients treated with tofacitinib, a JAK1/3 inhibitor, after a mean treatment period of 12 months, with a clinical response in 79%.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a> Furthermore, in the clinical trial with ruxolitinib, biopsies were taken from affected areas of the scalp at trial entry and after 12 weeks of treatment, measuring gene expression related to γ-interferon and cytotoxic T-cell activation. A notable reduction was observed in the expression of these inflammatory mediators of a type <span class="elsevierStyleSmallCaps">I</span> immune response, which could help to explain the effect of this drug.</p><p id="par0015" class="elsevierStylePara elsevierViewall">New treatment protocols are now being designed with ruxolitinib, baricitinib, and tofacitinib (<a href="http://www.clinicaltrials.gov/">http://www.clinicaltrials.gov</a>), JAK kinase inhibitors that we believe could revolutionize the treatment of AA. In contrast, we do not consider the widespread use of statins to be justified in this disease.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec933519" "palabras" => array:5 [ 0 => "Alopecia areata" 1 => "Statins" 2 => "JAK inhibitors" 3 => "Tofacitinib" 4 => "Ruxolitinib" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Morgado-Carrasco D, Rodríguez-Lobato E, Riera-Monroig J, Ferrando J. The Good and Bad News About New Drugs for Treating Alopecia Areata. Actas Dermosifiliogr. 2018;109:69–70.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Bibliografía" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of alopecia areata with simvastatin/ezetimibe" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Lattouf" 1 => "J.J. Jimenez" 2 => "A. Tosti" 3 => "M. Miteva" 4 => "T.C. Wikramanayake" 5 => "C. Kittles" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2014.11.006" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2015" "volumen" => "72" "paginaInicial" => "359" "paginaFinal" => "361" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25592347" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Alopecia areata (AA) and treatment with simvastatin/ezetimibe: Experience of 20 patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "C. Loi" 1 => "M. Starace" 2 => "B.M. Piraccini" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2015.09.071" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol." "fecha" => "2016" "volumen" => "74" "paginaInicial" => "e99" "paginaFinal" => "e100" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27085249" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "JAK3 as an emerging target for topical treatment of inflammatory skin diseases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A.K. Alves de Medeiros" 1 => "R. Speeckaert" 2 => "E. Desmet" 3 => "M. Van Gele" 4 => "S. De Schepper" 5 => "J. Lambert" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0164080" "Revista" => array:4 [ "tituloSerie" => "PLoS ONE." "fecha" => "2016" "volumen" => "11" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28002457" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "J. Mackay-Wiggan" 1 => "A. Jabbari" 2 => "N. Nguyen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1172/jci.insight.89790" "Revista" => array:5 [ "tituloSerie" => "JCI Insight." "fecha" => "2016" "volumen" => "1" "paginaInicial" => "e89790" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27699253" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "L.Y. Liu" 1 => "B.G. Craiglow" 2 => "F. Dai" 3 => "B.A. King" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2016.09.007" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol." "fecha" => "2017" "volumen" => "76" "paginaInicial" => "22" "paginaFinal" => "28" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27816293" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010900000001/v1_201801020547/S1578219017303682/v1_201801020547/en/main.assets" "Apartado" => array:4 [ "identificador" => "34945" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Resident's Forum" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010900000001/v1_201801020547/S1578219017303682/v1_201801020547/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017303682?idApp=UINPBA000044" ]
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 Noviembre | 10 | 10 | 20 |
| 2024 Octubre | 239 | 48 | 287 |
| 2024 Septiembre | 225 | 27 | 252 |
| 2024 Agosto | 122 | 51 | 173 |
| 2024 Julio | 110 | 28 | 138 |
| 2024 Junio | 117 | 44 | 161 |
| 2024 Mayo | 115 | 35 | 150 |
| 2024 Abril | 113 | 37 | 150 |
| 2024 Marzo | 101 | 43 | 144 |
| 2024 Febrero | 102 | 33 | 135 |
| 2024 Enero | 99 | 38 | 137 |
| 2023 Diciembre | 73 | 20 | 93 |
| 2023 Noviembre | 92 | 97 | 189 |
| 2023 Octubre | 83 | 133 | 216 |
| 2023 Septiembre | 70 | 121 | 191 |
| 2023 Agosto | 80 | 42 | 122 |
| 2023 Julio | 101 | 38 | 139 |
| 2023 Junio | 88 | 21 | 109 |
| 2023 Mayo | 95 | 25 | 120 |
| 2023 Abril | 99 | 26 | 125 |
| 2023 Marzo | 117 | 37 | 154 |
| 2023 Febrero | 81 | 30 | 111 |
| 2023 Enero | 77 | 31 | 108 |
| 2022 Diciembre | 85 | 40 | 125 |
| 2022 Noviembre | 51 | 41 | 92 |
| 2022 Octubre | 47 | 29 | 76 |
| 2022 Septiembre | 48 | 63 | 111 |
| 2022 Agosto | 36 | 60 | 96 |
| 2022 Julio | 39 | 66 | 105 |
| 2022 Junio | 33 | 93 | 126 |
| 2022 Mayo | 58 | 113 | 171 |
| 2022 Abril | 90 | 104 | 194 |
| 2022 Marzo | 97 | 53 | 150 |
| 2022 Febrero | 70 | 31 | 101 |
| 2022 Enero | 79 | 45 | 124 |
| 2021 Diciembre | 56 | 42 | 98 |
| 2021 Noviembre | 50 | 60 | 110 |
| 2021 Octubre | 61 | 64 | 125 |
| 2021 Septiembre | 49 | 65 | 114 |
| 2021 Agosto | 72 | 53 | 125 |
| 2021 Julio | 46 | 41 | 87 |
| 2021 Junio | 39 | 43 | 82 |
| 2021 Mayo | 51 | 58 | 109 |
| 2021 Abril | 107 | 112 | 219 |
| 2021 Marzo | 56 | 41 | 97 |
| 2021 Febrero | 66 | 52 | 118 |
| 2021 Enero | 48 | 43 | 91 |
| 2020 Diciembre | 40 | 42 | 82 |
| 2020 Noviembre | 52 | 48 | 100 |
| 2020 Octubre | 47 | 20 | 67 |
| 2020 Septiembre | 42 | 28 | 70 |
| 2020 Agosto | 27 | 28 | 55 |
| 2020 Julio | 33 | 21 | 54 |
| 2020 Junio | 35 | 40 | 75 |
| 2020 Mayo | 15 | 22 | 37 |
| 2020 Abril | 34 | 30 | 64 |
| 2020 Marzo | 29 | 23 | 52 |
| 2020 Febrero | 6 | 0 | 6 |
| 2020 Enero | 4 | 0 | 4 |
| 2019 Diciembre | 8 | 0 | 8 |
| 2019 Noviembre | 4 | 0 | 4 |
| 2019 Septiembre | 8 | 0 | 8 |
| 2019 Agosto | 4 | 0 | 4 |
| 2019 Julio | 3 | 0 | 3 |
| 2019 Junio | 6 | 0 | 6 |
| 2019 Mayo | 4 | 0 | 4 |
| 2019 Abril | 2 | 0 | 2 |
| 2019 Marzo | 4 | 0 | 4 |
| 2019 Enero | 2 | 0 | 2 |
| 2018 Diciembre | 5 | 0 | 5 |
| 2018 Noviembre | 1 | 0 | 1 |
| 2018 Octubre | 1 | 0 | 1 |
| 2018 Septiembre | 6 | 0 | 6 |
| 2018 Febrero | 102 | 40 | 142 |
| 2018 Enero | 115 | 50 | 165 |
| 2017 Diciembre | 9 | 17 | 26 |
Mostrar todo
